Table 2 Demographic and clinical characteristics of patients with Parkinson’s Disease-mild cognitive impairment (n = 20)
Mean (SD) | |
|---|---|
Age (years) | 65.6 (8.4) |
Education (years) | 10.3 (4.6) |
Sex (male/female) | 10/10 |
Age of onset (years) | 58.9 (7.5) |
Levodopa-equivalent daily dose (mg) | 555.7 (323.1) |
Cumulative Illness Rating Scale – severity | 1.6 (0.3) |
Cumulative Illness Rating Scale – comorbidity | 2.9 (1.8) |
Unified Parkinson’s Disease Rating Scale III | 24.1 (9.5) |
Hoehn & Yahr | 1.8 (0.7) |
Toronto Alexithymia Scale-20 | 50.7 (14.8) |
Interpersonal Reactivity Index | 84.4 (13.0) |
REM Sleep Behavior Disorder Screening Questionnaire | 3.6 (2.4) |
Parkinson’s Disease Quality of Life Questionnaire | 23.2 (13.0) |
Beck Depression Inventory II | 11.7 (6.0) |
Apathy Evaluation Scale | 12.1 (10.2) |
Barratt Impulsivity Scale-11 | 60.5 (8.1) |